MEIP Valuation

MEI Pharma Inc

Add to Watchlist

Advanced Chart

6.860

+0.31(4.733%)1D

Overview
Forecast
Valuation
Earnings

MEIP Relative Valuation

MEIP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MEIP is overvalued; if below, it's undervalued.

Historical Valuation

MEI Pharma Inc (MEIP) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.12. The fair price of MEI Pharma Inc (MEIP) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：7.19

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.23

P/B

Median3y

0.87

Median5y

2.63

-92.24

FCF Yield

Median3y

-178.81

Median5y

-109.85

Competitors Valuation Multiple

The average P/S ratio for MEIP's competitors is 20.03, providing a benchmark for relative valuation. MEI Pharma Inc Corp (MEIP) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap